Recent Finacing
Recent Raise
ISA Pharmaceuticals develops peptide-based immunotherapies using the Synthetic Long Peptide (SLP) platform, advancing ISA101b in late-stage trials for HPV16 cancers and programs for HBV, PRAME, other HPV types, and SARS-CoV-2.
